Eli Lilly's SWOT analysis: stock poised for growth amid challenges
Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...
Novo Nordisk's SWOT analysis: obesity drug leader faces supply hurdles
A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...
ConsumerAffairs3h
Weight loss drugs could be effective at fighting alcohol addiction, study finds
A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...
Ozempic maker Novo Nordisk failed to disclose more payments made to healthcare groups - watchdog
Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...
Psychology Today7h
Nature’s Ozempic
A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take ...
Ozempic left me with deadly bone-thinning disease, singer Avery, 30, reveals in heartbreaking confession: 'Please don't make the same mistake...'
In a tearful video posted to Instagram, the 30-year-old from Pheonix, Arizona admitted she took the drug after struggling ...
Ozempic, Wegovy may help mental health, substance disorders
An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.